# FDA Warning Letter: LXR Biotech, LLC
> 2023-08-01 · Division of Pharmaceutical Quality Operations III · `2b2c851426f26483`
## Letter
- **Company:** LXR Biotech, LLC
- **Posted Date:** 2023-08-01
- **Letter Issue Date:** 2023-07-17
- **Issuing Office:** Division of Pharmaceutical Quality Operations III
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*